✦ LIBER ✦

Phase II escalation study of sorafenib in patients with metastatic renal cell carcinoma who have been previously treated with anti-angiogenic treatment

✍ Scribed by Andrea Mancuso; Eugenio Donato Di Paola; Alvaro Leone; Alfonso Catalano; Fabio Calabrò; Linda Cerbone; Andrea Zivi; Carlo Messina; Silvia Alonso; Leonardo Vigna; Rita Caristo; Cora N. Sternberg

Book ID: 110923862
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 311 KB
Volume: 109
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.2011.10421.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II Trial of Intrapatient Dose-Es

A Phase II Trial of Intrapatient Dose-Escalated Sorafenib in Patients With Metastatic Renal Cell Carcinoma

✍ Robert Amato; Jim Zhai; James Willis; Somyata Saxena; Melissa DeFoe 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 705 KB

Randomized Phase II Trial of First-Line

Randomized Phase II Trial of First-Line Treatment With Sorafenib Versus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma

✍ Coplen, D.E. 📂 Article 📅 2009 🏛 Elsevier Science ⚖ 69 KB

Overall survival and good tolerability o

Overall survival and good tolerability of long-term use of sorafenib after cytokine treatment: final results of a phase II trial of sorafenib in Japanese patients with metastatic renal cell carcinoma

✍ Seiji Naito; Taiji Tsukamoto; Masaru Murai; Koichi Fukino; Hideyuki Akaza 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 411 KB

A phase II trial of first-line sorafenib

A phase II trial of first-line sorafenib in patients with metastatic renal cell carcinoma unwilling to receive or with early intolerance to immunotherapy: SOGUG Study 06-01

✍ Joaquim Bellmunt; Pablo Maroto-Rey; José M. Trigo; Joan Carles; Vicente Guillem; 📂 Article 📅 2010 🏛 Springer Milan 🌐 Spanish ⚖ 291 KB

Open-label, single-arm phase II study of

Open-label, single-arm phase II study of pemetrexed in the treatment of patients with recurrent or metastatic nasopharyngeal carcinoma who have had prior platinum-based chemotherapy

✍ Yang Zhang, Liping Zhao, Peiyu Huang, Jingxun Wu… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 201 KB

A phase II study of cediranib (AZD 2171)

A phase II study of cediranib (AZD 2171) in treatment naive patients with progressive unresectable recurrent or metastatic renal cell carcinoma. A trial of the PMH phase 2 consortium

✍ Srikala S. Sridhar, Mary J. Mackenzie, Sebastien J. Hotte, Som D. Mukherjee, Ian 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 285 KB